Leukemia, Myeloid, Acute
Showing NaN - NaN of 19
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)
Active, not recruiting
- Leukemia, Myeloid, Acute
- AG-120
- +2 more
-
Duarte, California
- +72 more
Aug 18, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)
Terminated
- Leukemia, Myeloid, Acute
-
Denver, Colorado
- +4 more
May 10, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)
Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)
Completed
- Leukemia, Myeloid, Acute
- Placebo
- +2 more
-
Los Angeles, California
- +121 more
Oct 25, 2021
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)
Terminated
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Boston, Massachusetts
- +5 more
Jun 11, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)
Completed
- Leukemia, Myeloid, Acute
- SGI-110 (guadecitabine)
- Treatment Choice
-
Scottsdale, Arizona
- +134 more
Dec 21, 2020
Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)
Terminated
- Leukemia, Myeloid, Acute
- PNK-007
- +3 more
-
Boston, Massachusetts
- +6 more
Jul 20, 2020
MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in United States (oral azacitidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- oral azacitidine
-
La Jolla, California
- +7 more
Nov 7, 2019
Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine 20 mg/m^2, Talacotuzumab 9 mg/kg)
Completed
- Leukemia, Myeloid, Acute
- Decitabine 20 mg/m^2
- Talacotuzumab 9 mg/kg
-
Orange, California
- +80 more
Mar 11, 2019
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Haploidentical Bone Marrow Transplantation
- GVHD prophylaxis
-
Duarte, California
- +16 more
Nov 28, 2017